This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fondazione Italiana Sclerosi Multipla—fism Onlus, Universita′ Degli Studi Di Milano. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 40 Years Active: 2018
Title: Marta Fumagalli: Innovator in Neurodegenerative Disease Treatment
Introduction
Marta Fumagalli is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of chemical compounds.
Latest Patents
Marta Fumagalli holds a patent for GPR17 receptor modulators. This patent involves chemical compounds that act on GPR17 receptors, which are useful in the treatment or amelioration of chronic and/or acute neurodegenerative diseases. These diseases include multiple sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, and renal diseases. She has 1 patent to her name.
Career Highlights
Throughout her career, Marta has worked with esteemed institutions such as Università Degli Studi Di Milano and Fondazione Italiana Sclerosi Multipla—FISM Onlus. Her work has been instrumental in advancing the understanding and treatment of various neurodegenerative conditions.
Collaborations
Marta has collaborated with notable colleagues, including Maria Pia Abbracchio and Mario Alberto Battaglia. Their combined expertise has contributed to the success of her research initiatives.
Conclusion
Marta Fumagalli's innovative work in the field of neurodegenerative diseases highlights her dedication to improving patient outcomes through scientific advancements. Her contributions are paving the way for future research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile